# Fennec Pharmaceuticals Inc.: Form 8-K, filed Dec 6, 2023

- Company: [Fennec Pharmaceuticals Inc.](/companies/fenc.md) (CIK 1211583)
- Form: 8-K
- Filed: 2023-12-06
- Accepted by EDGAR: Dec 6, 2023, 01:51 ET
- Period: 2023-12-04
- Accession: 0001104659-23-123728
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1211583/000110465923123728/tm2332198d1_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1211583/000110465923123728/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 2.03: New direct financial obligation
- Item 3.02: Unregistered sale of equity
- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1211583/000110465923123728/tm2332198d1_8k.htm

Filed Dec 6, 2023.
Source: SEC EDGAR, the filing index for accession 0001104659-23-123728. Last ingested by Listed: Oct 24, 2026, 15:11 ET. No prices; not investment advice.